ReviewClinical parkinsonism & related disorders2024

Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.

Stuart H Isaacson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.